Sampre Nutritions Ltd

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd experienced a pronounced decline on 5 Dec 2025, marked by exclusive selling activity and a sharp drop of 4.97% in a single trading session. This downward momentum extends over three consecutive days, signalling distress selling and a lack of buyer interest in the FMCG sector stock.

Sampre Nutritions Ltd experienced a pronounced decline on 4 Dec 2025, with the stock registering a 4.99% fall and exhibiting a rare scenario of exclusive selling interest. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within this FMCG sector player, marking a continuation of recent downward momentum.

Sampre Nutrition, a microcap player in the FMCG sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of volatile stock returns and contrasting fundamental indicators, prompting investors to reassess the company’s position within the fast-moving consumer goods landscape.

Sampre Nutritions Ltd experienced a pronounced decline on 3 Dec 2025, with the stock registering a sharp fall of 5.00% in a session dominated exclusively by sellers. This stark selling pressure contrasts markedly with the broader market, as the Sensex recorded a comparatively modest dip of 0.36% on the same day, signalling distress selling and a lack of buyer interest in the FMCG stock.

Sampre Nutritions has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention amid a backdrop of strong long-term performance.

Sampre Nutritions Ltd experienced a pronounced decline on 2 Dec 2025, with the stock registering a 4.99% fall in a session dominated exclusively by sellers. This sharp drop comes amid a three-day losing streak, signalling heightened distress selling and a lack of buyer interest in the FMCG sector stock.

Sampre Nutritions Ltd witnessed a sharp decline on 1 Dec 2025, marked by extreme selling pressure and an absence of buyers, resulting in a lower circuit scenario. The stock’s performance today starkly contrasts with the broader market, signalling distress selling and heightened investor caution.

Sampre Nutritions Ltd experienced a pronounced decline on 28 Nov 2025, marked by exclusive selling interest and a lower circuit scenario. The stock recorded a 5.0% drop on the day, contrasting sharply with the Sensex’s modest 0.12% gain, signalling distress selling and a lack of buyer support in the FMCG sector.

Sampre Nutritions witnessed extraordinary buying momentum today, hitting the upper circuit with a remarkable 4.9% gain. The stock’s performance stands in stark contrast to the broader market, reflecting a day dominated solely by buy orders and no sellers in the queue, signalling a potential multi-day circuit scenario.

Sampre Nutritions Ltd has encountered significant selling pressure on 24 Nov 2025, with the stock registering a sharp decline of 4.89% and exhibiting a rare scenario of exclusively sell orders in the queue. This distress selling signals heightened investor caution as the stock continues a six-day losing streak, underperforming both its sector and the broader market benchmarks.

Sampre Nutritions Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting no buying interest. This marks the fifth consecutive day of losses, reflecting distress selling signals and a challenging market sentiment for the FMCG company.

Sampre Nutritions Ltd experienced a pronounced decline on 20 Nov 2025, marked by a lower circuit scenario with exclusively sell orders dominating the market. The stock’s performance today reflects severe selling pressure, with no buyers stepping in, signalling distress selling and a challenging phase for the microcap FMCG company.

Sampre Nutritions Ltd has entered a phase of pronounced selling pressure, marked by a lower circuit and an absence of buyers on 19 Nov 2025. The stock’s performance today reflects a sharp decline of 4.93%, with all orders in the queue being sell orders, signalling distress selling and a lack of demand at current price levels.

Sampre Nutritions Ltd is currently experiencing significant selling pressure, with only sell orders present in the queue, signalling distress selling. The stock has recorded a sharp decline of 4.96% today, underperforming the Sensex which fell by 0.42%. This marks the second consecutive day of losses for the FMCG company, with a cumulative fall of 7.01% over this period.